Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.
2.

Treatment of the schizophrenia prodrome: is it presently ethical?

Cornblatt BA, Lencz T, Kane JM.

Schizophr Res. 2001 Aug 1;51(1):31-8. Review.

PMID:
11479063
3.

Relationship of schizotypal personality disorder to schizophrenia: genetics.

Torgersen S.

Schizophr Bull. 1985;11(4):554-63. Review.

PMID:
3909378
4.

Symptom assessment in schizophrenic prodromal states.

Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, Hoffman R, Davidson L.

Psychiatr Q. 1999 Winter;70(4):273-87. Review.

PMID:
10587984
5.

The use of pharmacotherapy in the prodrome of schizophrenia.

Remington G, Shammi C.

CNS Spectr. 2004 Aug;9(8):579-86. Review. Erratum in: CNS Spectr. 2004 Dec;9(12):888.

PMID:
15273650
6.

Schizotypal disorder: at the crossroads of genetics and nosology.

Battaglia M, Torgersen S.

Acta Psychiatr Scand. 1996 Nov;94(5):303-10. Review.

PMID:
9124076
7.

[Early recognition and early treatment of schizophrenia: chance or dilemma?].

Resch F.

Z Kinder Jugendpsychiatr Psychother. 2008 Jul;36(4):235-44. doi: 10.1024/1422-4917.36.4.235. Review. German.

PMID:
18654955
8.

[Analysis of monozygotic twins, discordent with regard to manifest schizophrenia, from a clinical point of view (review of the literature)].

Moskalenko VD.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1978;78(3):437-44. Review. Russian. No abstract available.

PMID:
347847
9.

[Electrophysiologic endophenotype in schizophrenia].

Guillin O.

Encephale. 2007 Jun;33 Pt 3:S369-70. doi: 10.1016/S0013-7006(07)74583-9. Review. French. No abstract available.

PMID:
19101352
10.
11.

[Neurological soft signs as a candidate for endophenotype of schizophrenia].

Kałuzyńska O, Rabe-Jabłońska J.

Psychiatr Pol. 2014 Jan-Feb;48(1):5-18. Review. Polish.

PMID:
24946431
12.

Validating schizotaxia and its place in studies of preventing schizophrenia by psychopharmacological intervention.

Tsuang MT, Stone WS, Tarbox SI, Faraone SV.

Essent Psychopharmacol. 2005;6(2):91-103. Review.

PMID:
15765793
13.

Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions.

Cannon TD, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Huttunen MO, Keshavan MS, Seidman LJ, Tsuang MT.

Schizophr Bull. 2003;29(4):653-69. Review.

PMID:
14989405
14.

Toward a better identification and treatment of schizophrenia prodrome.

Bota RG, Sagduyu K, Filin EE, Bota DA, Munro S.

Bull Menninger Clin. 2008 Summer;72(3):210-27. doi: 10.1521/bumc.2008.72.3.210. Review.

PMID:
18990056
15.

Heredity and environment in schizophrenia, revisited. The contribution of twin and high-risk studies.

Stabenau JR, Pollin W.

J Nerv Ment Dis. 1993 May;181(5):290-7. Review.

PMID:
8501444
16.

[Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].

Lecardeur L, Meunier-Cussac S, Dollfus S.

Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Review. French.

PMID:
23528322
17.

[Prodromes of schizophrenia: consensus or confusion?].

Teyssier JR.

Encephale. 2013 May;39 Suppl 1:S1-7. doi: 10.1016/j.encep.2012.11.002. Epub 2013 Jan 23. Review. French.

PMID:
23351932
18.

[Clinico-genealogical studies of schizophrenia in the latest literature (1985-1990) (review of the literature)].

Orlova VA, Ozerova NI, Demikova NS, Trubnikov VI.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1992;92(4):100-5. Review. Russian. No abstract available.

PMID:
1333697
19.

Preventing severe mental illnesses--new prospects and ethical challenges.

Schaffner KF, McGorry PD.

Schizophr Res. 2001 Aug 1;51(1):3-15. Review.

PMID:
11479061
20.

Psychosis treatment prior to psychosis onset: ethical issues.

McGlashan TH.

Schizophr Res. 2001 Aug 1;51(1):47-54. Review.

PMID:
11479065

Supplemental Content

Support Center